🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Halia Therapeutics Presents Two AAIC 2026 Posters on HT-4253 for Alzheimer's Prevention in APOE4 Carriers

Tremonton Archived • July 13, 2026 • 2 views
Halia Therapeutics Presents Two AAIC 2026 Posters on HT-4253 for Alzheimer's Prevention in APOE4 Carriers
Preclinical data show HT-4253 reduces neuroinflammation and tau pathology; a second details a Phase 2a biomarker trial in pre-symptomatic APOE4 carriers via UAE genomics
Source: https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original
"We build AI or anything ICST"
"Output is a realization of Input."

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Monetize your website or boost your business with Code-Oryx. Join the network today!"